REGISTERED
on 13 Aug 2024
Last Applicant/ Owned by
CH-6900 Lugano
CH
Serial Number
79369113 filed on 09th Jan 2023
Registration Number
7470276 registered on 13th Aug 2024
Correspondent Address
Barry I. Friedman
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
EPIDEX
Tissue engineering, namely, genetic engineering of human tissue for others; Analysis of human tissues for medical research; scientific research services, namely, the isolation and cultivation of human tissues and cells; genetic engineering services; scientific research in the field of genetics and genetic engineering; advisory services relating to gene therapy research; research in the field of ge Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Stem cell therapy services; medical services, namely, analysis of human tissues for medical treatment purposes; stem cell bank services for medical transplantation; medical services, namely, the removal, treatment and processing of stem cells; medical services, namely, the removal, treatment and processing of human cells; medical and health care services, namely, DNA screening for medical purposes, genetics counseling and genetic testing for medical purposes; genetic testing for medical use; genetic counseling; regenerative medicine services; medical services in the field of treatment of chronic conditions; medical services in the field of injury healing; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Tissue engineering, namely, genetic engineering of human tissue for others; Analysis of human tissues for medical research; scientific research services, namely, the isolation and cultivation of human tissues and cells; genetic engineering services; scientific research in the field of genetics and genetic engineering; advisory services relating to gene therapy research; research in the field of gene therapy; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medicines for use in tissue regeneration and wound healing in the management of acute and chronic wounds and rare diseases; enzymes for medical use; pharmaceutical preparations for wound healing in the management of acute and chronic wounds and rare diseases; cells for medical use; living cells for medical use; pharmaceutical preparations containing stem cells for wound healing in the management of acute and chronic wounds and rare diseases; stem cells for medical use; stem cells for veterinary use; transplants being implants comprising living tissue; surgical implants made from living tissues; surgical implants grown from stem cells being living tissue; bone void fillers made from living tissues; tissue-regenerative pharmaceutical preparations; enzymes for veterinary use; all the above mentioned goods not related to the treatment of epilepsy or other neurological disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79369113
Mark Type
No Service Mark
Attorney Docket Number
No 9766/002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.11.20 -
Rectangles inside another rectangle
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 13th Aug 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 13th Aug 2024 | REGISTERED-PRINCIPAL REGISTER |
| 28th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 28th May 2024 | PUBLISHED FOR OPPOSITION |
| 08th May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 25th Apr 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Apr 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 25th Apr 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 25th Apr 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |